Cetaben

This classification denotes an anti-lipidemic agent with the molecular formula C23H39NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, DTL5W0113X chemically known as benzoic acid, 4-(hexadecylamino)- but generally known as cetaben, which bears US NIH Compound Identifier 47263. European Medicines Agency schedules Cetaben in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07444MIG. The term CETABEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18). Most nations schedule cetaben under HS 29224995 and SITC 51465. As of Q4 2014, CETABEN remains the US FDA Preferred Term for this commodity. Cetaben bears US NLM identifiers UMLS ID C0055140 and NCI Concept Code C73814. SMILES: OC(=O)C1CCC(NCCCCCCCCCCCCCCCC)CC1.